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Background: 
COVID-19 is associated with severe respiratory failure and high mortality in critically ill 
patients.2,4,5 Neurologic manifestations of the disease, including delirium and coma, may also be 
associated with poor clinical outcomes. Delirium is associated with prolonged mechanical 
ventilation and mortality.3 this study sought to describe the rates, duration, and severity of 
delirium in patients admitted to the ICU with COVID-19. 
Methods: 
A retrospective, observational study was conducted from March 1stto April 27th, 2020, at Indiana 
University Health Methodist and Eskenazi Health Hospitals. The delirium measurements were 
extracted in the first 14 days of the ICU stay, using the Richmond Agitation and Sedation Scale 
(RASS) and the CAM-ICU and CAM-ICU7, for those with a positive COVID-19 diagnosis. The 
primary outcomes were delirium rates and duration; the secondary outcome was delirium 
severity. Descriptive statistics and median group comparisons were done using SAS v9.4. 
Results:  
Of 144 patients in the study, 73.6% experienced delirium and 76.4% experienced delirium or 
coma. The median delirium or coma duration was 7 days (IQR: 3-10), and the median delirium 
duration was 5 days (IQR: 2-7). The median CAM-ICU-7 score was 6 (IQR: 2-7) signifying 
severe delirium. Mechanical ventilation was associated increased risk of developing delirium 
(OR: 22.65, 95% CL: 5.24-97.82). Mortality was also more likely in patients experiencing 
delirium: 26.4% compared to 15.8% in patients without delirium.  
Conclusion:  
Of the 144 patients included, 73.6% experienced delirium lasting on average 5 days: the median 
delirium score being severe. Mechanical ventilation was also associated with greater odds of 
developing delirium. Because Covid-19 is associated with high rates of delirium, leading to 
increased rates of functionality disability, more resources and attention are needed to prevent 
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